Table 3.
Nuclei | Pre (SD) | PBwk2 (SD) | PBwk4 (SD) |
---|---|---|---|
DCN | 0.279 (.093) | 0.306 (.133) (F(2,39)=0.327, p>0.05) |
0.280 (.051) (F(2,39)=0.327, p>0.05) |
IC | 0.262 (.056) | 0.351 (.109)* (F(2,39)=3.934, p=0.030) |
0.286 (.088) (F(2,39)=3.934, p>0.05) |
MGB | 0.355 (.076) | 0.390 (.082) (F(2,39)=1.358, p>0.05) |
0.419 (.137) (F(2,39)=1.358, p>0.05) |
AC | 0.255 (.034) | 0.279 (.066) (F(2,39)=1.951, p>0.05) |
0.245 (.034) (F(2,39)=1.951, p>0.05) |
AMG | 0.341 (.082) | 0.424 (.136) (F(2,39)=2.514, p>0.05) |
0.361 (.073) (F(2,39)=2.514, p>0.05) |
CC | 0.622 (.101) | 0.615 (.110) (F(2,100)=1.469, p>0.05) |
0.582 (.098) (F(2,100)=1.469, p>0.05) |
p<0.05.
Changes in FA values across nuclei between week 2 pre- and post-blast. A significant increase occurred in the IC between week 2 pre- and post-blast. ANOVA and post-hoc Bonferroni tests.
MGB, medial geniculate body; ANOVA, analysis of variance; IC, inferior colliculus; CC, corpus callosum; AMG, amygdala; DCN, dorsal cochlear nucleus; SD, standard deviation; Pre, pre-blast; PBwk2, post-blast week 2; PBwk4, post-blast week 4.